The FINISH-3 Trial: A Phase 3, International, Randomized, Single-Blind, Controlled Trial of Topical Fibrocaps in Intraoperative Surgical Hemostasis Grant V. Bochicchio, MD, MPH, FACS, Navyash Gupta, MD, FACS, Robert J. Porte, MD, PhD, Kenneth L. Renkens, MD, FACS, Piet Pattyn, MD, PhD, Baki Topal, MD, PhD, Roberto Ivan Troisi, MD, PhD, FEBS, William Muir, MD, Ian Chetter, MD, PhD, Daniel L. Gillen, PhD, Linda A. Zuckerman, PhD, Paul A. Frohna, MD, PhD, PharmD Journal of the American College of Surgeons Volume 220, Issue 1, Pages 70-81 (January 2015) DOI: 10.1016/j.jamcollsurg.2014.09.019 Copyright © 2015 American College of Surgeons Terms and Conditions
Figure 1 Patient disposition. Journal of the American College of Surgeons 2015 220, 70-81DOI: (10.1016/j.jamcollsurg.2014.09.019) Copyright © 2015 American College of Surgeons Terms and Conditions
Figure 2 Time to hemostasis. Time to hemostasis during the 5-minute evaluation period is shown for (A) patients undergoing spinal surgical procedures, (B) vascular surgical procedures, (C) hepatic resection, and (D) soft tissue dissection. p Values were determined using the log-rank test. Journal of the American College of Surgeons 2015 220, 70-81DOI: (10.1016/j.jamcollsurg.2014.09.019) Copyright © 2015 American College of Surgeons Terms and Conditions